BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 32290531)

  • 1. Matrix Metalloproteinases: How Much Can They Do?
    Ă…gren MS; Auf dem Keller U
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.
    Georgiadis D; Yiotakis A
    Bioorg Med Chem; 2008 Oct; 16(19):8781-94. PubMed ID: 18790648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases (MMPs) in health and disease: an overview.
    Malemud CJ
    Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.
    Raeeszadeh-Sarmazdeh M; Do LD; Hritz BG
    Cells; 2020 May; 9(5):. PubMed ID: 32466129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease.
    Zhong S; Khalil RA
    Biochem Pharmacol; 2019 Jun; 164():188-204. PubMed ID: 30905657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous and synthetic MMP inhibitors in CNS physiopathology.
    Baranger K; Rivera S; Liechti FD; Grandgirard D; Bigas J; Seco J; Tarrago T; Leib SL; Khrestchatisky M
    Prog Brain Res; 2014; 214():313-51. PubMed ID: 25410364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular regulation of metalloproteinases.
    Yamamoto K; Murphy G; Troeberg L
    Matrix Biol; 2015; 44-46():255-63. PubMed ID: 25701651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
    Levin M; Udi Y; Solomonov I; Sagi I
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteinases and plaque rupture: unblocking the road to translation.
    Newby AC
    Curr Opin Lipidol; 2014 Oct; 25(5):358-66. PubMed ID: 25089553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there new hope for therapeutic matrix metalloproteinase inhibition?
    Vandenbroucke RE; Libert C
    Nat Rev Drug Discov; 2014 Dec; 13(12):904-27. PubMed ID: 25376097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metalloproteinases: A parade of functions in matrix biology and an outlook for the future.
    Apte SS; Parks WC
    Matrix Biol; 2015; 44-46():1-6. PubMed ID: 25916966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metalloproteinases and metalloproteinase inhibitors in age-related diseases.
    Gargiulo S; Gamba P; Poli G; Leonarduzzi G
    Curr Pharm Des; 2014; 20(18):2993-3018. PubMed ID: 24079771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Biochemistry and Physiology of A Disintegrin and Metalloproteinases (ADAMs and ADAM-TSs) in Human Pathologies.
    Sharma D; Singh NK
    Rev Physiol Biochem Pharmacol; 2023; 184():69-120. PubMed ID: 35061104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix Metalloproteinases: A challenging paradigm of cancer management.
    Alaseem A; Alhazzani K; Dondapati P; Alobid S; Bishayee A; Rathinavelu A
    Semin Cancer Biol; 2019 Jun; 56():100-115. PubMed ID: 29155240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging roles of ADAM and ADAMTS metalloproteinases in cancer.
    Rocks N; Paulissen G; El Hour M; Quesada F; Crahay C; Gueders M; Foidart JM; Noel A; Cataldo D
    Biochimie; 2008 Feb; 90(2):369-79. PubMed ID: 17920749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction: MMPs, ADAMs/ADAMTSs research products to achieve big dream.
    Okazaki I; Nabeshima K
    Anticancer Agents Med Chem; 2012 Sep; 12(7):688-706. PubMed ID: 22292751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and clinical insights of matrix metalloproteinases into cancer spread and potential therapeutic interventions.
    Siddhartha R; Garg M
    Toxicol Appl Pharmacol; 2021 Sep; 426():115593. PubMed ID: 34038713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MMPs and ADAMs/ADAMTS inhibition therapy of abdominal aortic aneurysm.
    Li Y; Wang W; Li L; Khalil RA
    Life Sci; 2020 Jul; 253():117659. PubMed ID: 32283055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of metalloproteinases in tendon pathophysiology.
    Sbardella D; Tundo GR; Fasciglione GF; Gioia M; Bisicchia S; Gasbarra E; Ippolito E; Tarantino U; Coletta M; Marini S
    Mini Rev Med Chem; 2014; 14(12):978-87. PubMed ID: 25373850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of MMPs and ADAM/ADAMTS.
    Malemud CJ
    Biochem Pharmacol; 2019 Jul; 165():33-40. PubMed ID: 30826330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.